Acyclovir Injection Shortage
Last Updated: May 14, 2024
Status: Current
Products Affected - Description
-
- Acyclovir sodium injection, Eugia US, 50 mg/mL, 10 mL vial, 10 count, NDC 55150-0154-10
- Acyclovir sodium injection, Eugia US, 50 mg/mL, 20 mL vial, 10 count, NDC 55150-0155-20
- Acyclovir sodium injection, Fresenius Kabi, 50 mg/mL, 10 mL vial, 10 count, NDC 63323-0325-10
- Acyclovir sodium injection, Fresenius Kabi, 50 mg/mL, 20 mL vial, 10 count, NDC 63323-0325-20
Reason for the Shortage
-
- Eugia did not provide a reason for the shortage.
- Fresenius Kabi has acyclovir on shortage due to increased demand.
Available Products
-
- There is insufficient supply for usual ordering
Estimated Resupply Dates
-
- Eugia has acyclovir sodium 50 mg/mL 10 mL and 20 mL vials on intermittent back order and the company is releasing product as it becomes available.
- Fresenius Kabi has acyclovir sodium 50 mg/mL 10 mL and 20 mL vials on back order and the company estimates a release date of late-May 2024 for the 10 mL vials and mid- to late-June 2024 for the 20 mL vials.
Updated
Updated May 14, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 21, 2024 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2024, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.